CRISPR/Cas9 genome editing to treat sickle cell disease

CRISPR/Cas9 genome editing to treat sickle cell disease

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

Detaylı Bibliyografya
Yazar: Ullah, Mohammad
Diğer Yazarlar: Islam, Farzana
Materyal Türü: Tez
Dil:English
Baskı/Yayın Bilgisi: Brac University 2023
Konular:
SCD
CRISPR/Cas9
Hematopoietic stem/progenitor cells
Fetal hemoglobin
Gene editing tools
Genetic engineering > Research
Gene therapy > Research
Biotechnology
Online Erişim:http://hdl.handle.net/10361/19355

Internet

http://hdl.handle.net/10361/19355

Benzer Materyaller